United States · Bill · S
S. 726 (116th)
Personal Care Products Safety Act
Introduced
7 March 2019
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1742)
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Personal Care Products Safety Act This bill authorizes the Food and Drug Administration (FDA) to take various actions with respect to the regulation of cosmetics, such as collecting fees from manufacturers and distributors to fund cosmetics safety activities. The bill also authorizes the FDA to suspend the distribution of products that have a reasonable probability of causing serious adverse health consequences.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 7 March 2019
Introduced in Senate (PDF)
Introduced in Senate · EN · 7 March 2019
Introduced in Senate
summary · EN · 7 March 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/senate-bill/726
- Open data entity: https://api.congress.gov/v3/bill/116/s/726